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ABSTRACT     
Disorder of physiological  signaling  functions of reactive oxygen  species  (ROS)  superoxide (ROS are  chemically reactive  molecules containing  oxygen), 
hydrogen peroxide, reactive nitrogen species (RNS) nitric oxide and peroxynitrite are an important feature of diabetes mellitus. The balance between the 
production of ROS, notably superoxide anion (O
−2) and hydrogen peroxide (H2O2), and the antioxidant defense system that includes superoxide dismutase 
(SOD) and peroxidases, determines the degree of oxidative stress. An increased production and/or decreased metabolism of ROS have been implicated in the 
pathogenesis of renal injury in diabetes mellitus (DM). Thus the regulation of ROS generation in diabetes by antioxidants seems to be a promising target for 
management of Diabetic nephropathy.   
Keywords: NO, eNOS, ROS, PKC, NOX4 
 
INTRODUCTION 
Diabetes  mellitus,  a  metabolic  disorder  associated  with 
various  macrovascular  and  microvascular  complications 
including  nephropathy.  Nephropathy  is  one  of  major 
microvasular  complication  associated  with  the  chronic 
diabetes mellitus. The uncontrolled glucose level results in 
structural as well as functional changes in the kidney. The 
common structural changes such as thickening of glomerular 
basement  membrane,  glomerulosclerosis,  glomerular 
hypertrophy,  podocyte  loss,  mesangial  cell  expansion,  and 
tubulointerstitial fibrosis. After numerous afford it has been 
noted that the multiple signaling pathways are involved in the 
pathogenesis  of  diabetic  nephropathy  which  include 
angiotensin-II  (ANG-II),  endothelin-1  (ET-1),  advanced 
glycation  end  products  (AGEs),  endothelial  nitric  oxide 
synthase  (eNOS),  ROS,  transforming  growth  factor-beta 
(TGF-β), vascular endothelial growth factor (VEGF), nuclear 
factor kappa B (NF-ҡB), lipid peroxidation, and collagen-4 
but  it  is  worthwhile  to  note  that  ROS-RNS  mediated 
oxidative  stress  through  Nicotinamide adenine  dinucleotide 
phosphate (NADPH) overproduction seems to be a centrally 
involved  in  the  pathogenesis  of  diabetes  induced 
nephropathy.  Major  ROS  &  RNS  consist  of  paramagnetic 
free radicals (superoxide O2
.-, hydroxyl OH
-, peroxy radical 
ROO, nitric oxide free radical, diamagnetic molecules (H2O2 
and  peroxynitrite  ONOO
−)  which  are  products  of  the 
reactions of these free radicals. Thereby, the objective of this 
review is the suppression of damaging ROS-RNS signalling 
in  biological  processes  whereby  ROS-RNS  induced  by 
NADPH play a major role in pathogenesis and progression of 
diabetes induced nephropathy. 
NADPH OXIDASE 
NADPH oxidase is a critical component for ROS generation 
in  macrophages  and  neutrophils  and  many  other  cell 
including mesangial cells. NADPH oxidase, a major source 
of  superoxide  generation,  is  composed  of  six  subunits 
including  two  membrane  associated  components  (p22 
phagocytic oxidase (phox) and gp91phox) and four cytosolic 
components (P47phox, p40phox, p67phox, and small GTPase 
Rac).  NADPH  oxidase  is  activated  by  membrane 
translocation of three cytosolic proteins (p47phox, p67phox, 
and  small  GTPase  Rac).  At  the  membrane,  these  proteins 
assemble with gp91phox-p22phox heterodimer and induce a 
conformational  change  of  gp91phox,  which  results  in 
superoxide  production.  The  activated  NADPH  oxidase 
generates superoxides by transferring an electron inside the 
cells across the membrane, and the electrons thus transferred 
are coupling with molecular oxygen to generate superoxides, 
known as reactive free radicals
1.  
NADPH  is  formed  during  glycolysis  or  oxidative 
phosphorylation  and  exerts  antioxidant  activity  by 
regeneration  of  reduced  glutathione.  Glutathione  act  as 
important intracellular antioxidant by reacting with ROS and 
organic peroxides
2-3. Thus, antioxidant defense system  will 
reduce  the  level  of  NADPH  by  coversion  of  NADPH  to 
NADP
+. In renal vessels, macula densa, thick ascending limb 
of loop of henle, distal tubules, collecting ducts, interstitial 
fibroblasts,  glomerular  podocyte  and  messengial  cells  are 
documented to consist of enzyme NADPH oxidase which is 
responsible for significant production of superoxide radical
4. 
Activation of NADPH oxidase may be due to assembly of the 
subunits and  translocation  of  p47phox  to  the  membrane  is 
necessary. 
NADPH OXIDASE INDUCE NOS 
Nitric  oxide  (NO)  production  plays  a  central  role  in 
modulating endothelial function
5. NO is generated from the 
metabolism  of  L-arginine  by  the  enzyme  NOS,  of  which 
there are three isoforms: the constitutive types, brain (bNOS) 
and  endothelial  (eNOS),  and  the  inducible  type  (iNOS)
6. 
iNOS  is  induced  de  novo  by  various  stimuli,  including 
hyperglycemia
7,  while  the  mitochondrial-generated 
superoxide  can inhibit  eNOS, although  enough  NO  is  still 
produced
8.  NADPH  oxidase  generated  superoxide  radicals 
can react with NO forming peroxynitrite, which is a potent 
oxidant  and  nitrosylating  agent.  Furthermore,  this  reaction 
can  cause  NO  deficiency,  NO  normally  regulates 
tubuloglomerular  feed  back  and  renal  blood  flow,  and  is 
involved in regulation of natriuresis. The NO deficiency can 
be  worsened  by  the  fact  that  oxidative  stress  promotes 
activation  of  vasoconstrictors
9.  Moreover,  NO  deficient 
animal  models  have  shown  to  develop  glomerulosclerosis 
and proteinuria, as well as hypertension and renal failure
9. 
Expression of p47phox is increased in podocytes, glomeruli, 
loop of henle, cortical distal tubules, and medullary collecting 
ducts in diabetic rats
10-11. Further NADPH oxidase inhibitor, 
apocyanin  decreases  the  expression  of  gp91phox  and Tarar S.K et al. IRJP 2012, 3 (7) 
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activation  of  p47phox  in  diabetic  rats
11.  Furthermore, 
increased  NADPH  oxidase  activity  will  decrease 
NADPH/NADP
+ ratio, causing oxidative stress by TCA cycle 
enzyme  complex  α-ketoglutarate  dehydrogenase
12.  In 
addition  to  high  glucose,  free  fatty  acid
13,  oxidized  LDL, 
hyperlipidemia
14-15,  ANG-II  in  mesangial  cell
16,  and 
endothelial cell
17 are reported to activate NADPH  oxidase. 
Furthermore,  increased  superoxide  produced  within  the 
glomerular  microcirculation  decrease  NO  bioactivity  on 
mesangial contraction and arterioal tone and may contribute 
to  many  of  the  renal  hemodynamic  and  vascular 
abnormalities in diabetic nephropathy
18. 
On the other hand a major defense of endothelial cells against 
vascular injury is eNOS, which generates NO in the presence 
of  the  substrate  L-arginine,  and  the  cofactor  (6R)-5-6-7-8-
tetrahydro-Lbiopterin  (BH4).  NADPH  oxidases  are  major 
sources of ROS in endothelium and are activated in animal 
models of hypertension and diabetes. Superoxide (O2
.-) reacts 
avidly  with  vascular  NO  to  form  peroxynitrite  (ONOO
-), 
leading to BH4 oxidation and subsequent promotion of O2
. - 
production by eNOS itself, so-called “eNOS uncoupling”
19-20. 
Uncoupled  eNOS  is  detected  in  conditions  associated  with 
oxidant stress, hypertension and diabetes
19. 
Recently, it has been suggested that eNOS-derived NO is a 
critical regulator of endothelial junctional integrity and serves 
to  maintain  the  low  basal  permeability  of  endothelium
21. 
Importantly,  a  recent  study  has  demonstrated  that  NO 
prevents  high  glucose-induced  endothelial  apoptosis  by 
suppressing NF-ҡB activity
22. In addition, it has been shown 
that  NO  prevents  aldose  reductase  activation,  sorbitol 
accumulation  and  potentially  suppresses  vascular 
complications during diabetes
23. 
NADPH OXIDASE INDUCE ROS 
In diabetes, NADPH oxidase is a major source of generation 
of ROS. NADPH oxidase is located in plasma membrane of 
various renal  cell types,  including mesangial and  proximal 
tubular cells, vascular smooth muscle cells, endothelial cells 
and  fibroblasts
24.  The  ROS  are  generated  via  NADPH-
oxidase  system  by  the  interaction  of  membrane-bound 
flavocytochrome  b558  (heterodimer  of  gp91phox  and 
p22phox) with various cytosolic proteins (p47phox, p67phos, 
p40phox, and a GTP-binding protein, p21rac)
25-26 as a result 
O2
.  -  is  generated,  which  gets  dismutated  to  H2O2.  The 
relevance of this system in renal pathobiology lies in the fact 
that  Nox  4,  a  homologue  of  neutrophil  gp91phox,  is 
expressed  in  the  kidney
25.  Besides  AGEs,  PKC,  DAG, IP3 
(inositol 1, 4, 5-trophosphate), and TGF-β the metabolites of 
cyclo-oxygenase  (COX)  pathway  and  can  also  activate 
NADPH oxidase under high glucose ambience
25-26. The high 
glucose, as compared to normal glucose, induced a three-fold 
increase in ROS production by bovine aortic endothelial cells 
and  that  overexpression  of  uncoupling  protein  (UCP)-1  or 
manganese  superoxide  dysmutase  (MnSOD)  effectively 
prevented  ROS  overproduction  by  high  glucose  suggesting 
that the mitochondria is the source of high glucose-induced 
superoxide  generation
28.  Moreover,  decreased  fibronectin 
expression  by  the  inhibitors  of  oxidase,  apocynin,  and 
diphenylene  iodonium  (DPI)  suggests  a  potential  role  of 
NADPH  oxidase  in hyperglycemic  injury  and relevance  in 
redox-sensitive  processes,  i.e.,  cell  growth,  apoptosis, 
migration, and extracellular matrix (ECM) modeling that are 
modulated  by  various  signaling  pathways  and transcription 
and growth factors such as TGF-β.  
On  the  other  hand  the  angiotensin  converting  enzyme 
inhibitor  (ACEi)  and  ANG-II  receptor  blocker  (ARB) 
inhibited  p47phox  and  nitrotyrosine  expression  in  diabetic 
kidney  suggesting  that  inhibition  of  ANG-II  may  confer 
renoprotection  in  diabetes,  in  part,  through  prevention  of 
ROS overproduction
19, 27. 
 
 
Fig-1. The NADPH mediated ROS-RNS signalling involve in Diabetic 
Nephropathy. 
 
PKC-Protein  Kinase  C,  ROS-Reactive  oxygen  species,  e 
NOS-endothelial nitric oxide synthase, ICAM-1 (Intercellular 
Adhesion Molecule 1), Akt also known as Protein Kinase B 
(PKB), Tetrahydrobiopterin deficiency (THBD, BH4D) also 
called THB or BH4 deficiency. High glucose (HG)-induced 
ROS  formation  resulted  in  the  phosphorylation  of  Ser36-
p66shcA protein that promoted further ROS formation. ROS 
overproduction  activated  Akt/PKB  kinase,  which 
phosphorylated  and  inactivated  FOXO3a  protein,  enhanced 
oxidative stress. Diabetes increased the levels of transforming 
growth factor TGFβ that led to the inactivation of phospho- 
FOXO3a protein and the enhanced oxidative stress.  
CONCLUSION AND DISCUSSION 
Present  findings  demonstrate  importance  of  NADPH 
mediated  ROS  and  RNS  signaling  in  many  enzymatic 
cascades regulating the development of diabetic nephropathy. 
It  might  also  be  suggested  that  the  deregulation  of  ROS 
signaling is probably the beginning of pathological changes 
in diabetes. 
Investigation  of  ROS  and  RNS  signaling  in  enzymatic 
cascades  which  are  responsible  for  developing  diabetic 
nephropathy  could  be  a  fascinating  task,  promising  the 
discovery of new pharmaceutical agents and methods for the 
treatment  of  these  pathologies.  Aforementioned  findings 
suggest the potential usefulness of the inhibitors of ROS & 
RNS signaling in gene/enzymatic processes for the treatment 
of diabetic nephropathy. 
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